Purpose:Discussion TCM on Polycystic Ovary Syndrome of awareness, through clinical research, used YiQiJianPiHuaTan Decoction treatment more SAC ovarian integrated levy spleen virtual phlegm resistance card, objective evaluation Yi gas health spleen phlegm party on more SAC ovarian integrated levy spleen virtual phlegm resistance card patients of treatment effect, especially on TCM card waiting integral, and body quality index, and ovulation situation, and pregnancy situation, and menstrual recovery situation, and sexual hormone level and the b Super-equal-area by produced of effect, and evaluation its clinical effect and the security, for clinical application provides objective pursuant to.Methods:Clinical study on a randomized, controlled study of methods, consistent with polycystic ovarian syndrome in patients with spleen-deficiency syndrome of phlegm blocking, according to1:1control principles, randomly divided into a control group and treatment group. In primary care and Western medicine on a regular basis for treatment, control group given Daeng-35,2mg,1daily,1a day treatment group given water decoction of traditional Chinese medicine agent, sooner or later, take it twice.3for1course of menstrual cycle, continuous observation of2courses. Evaluation of each of the two groups before and after treatment the clinical symptoms and signs of change, observation points of TCM syndromes before and after treatment, body mass index, ovulation, pregnancy, menstruation recovery situation, sex hormones and b Super-equal-index. Statistical software for statistical analysis of all data to SPSS16.0.Results:Polycystic ovary syndrome in patients with spleen-deficiency and phlegm stagnation syndrome in60cases randomly divided into2groups,30cases of the treatment group, control group of30cases, two groups of patients before treatment in the course of ages, and infertility, legitimate condition indicators for age, BMI, laboratory examination, symptoms are not of significant differences.1.Treatment30cases, total effective rate90%. Control group of30cases, total effective rate73.33%. Treatment of total effective rate is better than the control group, statistically significant (P<0.05).2.Symptoms and signs improvement:the treated group after treatment had a significant improvement. The symptoms improvement of the treated group was better than the controlled group (P<0.01).3.Obesity indicators:decreased after treatment of two groups of patients with BMI, compared with before treatment had significant difference (P<0.01), differences in BMI to improve treatment group compared with the control group (P<0.05).4.Clinical symptoms and signs:two groups of patients with the menstrual cycle have significantly improved, differences significant (P<0.01), the treatment group improved menstrual cycle better than the control group, statistically significant differences (P<0.05); treatment of3cases of pregnancy after treatment, control group no pregnancy. Two hairy has improved significantly (P<0.01), the treatment effect is better than the control group (P<0.05), two groups of treatment for acne has significant improvement (P<0.01), the treatment effect is better than the control group (P<0.05).5.Sex hormone levels:both groups are have a significant effect on decreasing androgen (P<0.01), lower androgen treatment group than the control group (P<0.05), two sets of E2is no significant differences before and after treatment (P>0.05). Two groups shall have a significant effect on lower LH, LH/FSH (P<0.01), the treatment group than the control group (P<0.05), two sets of FSH no significant differences before and after treatment (P>0.05).6.B-mode ultrasound imaging:two sets of declining ovarian volume after treatment than before treatment (P<0.01), the treatment group and the control group without significant difference (P>0.05). Basal body temperature after treatment in two sets of double rate per cent and36.67%per cent respectively, the treatment group than the control group (P<0.05).7.safety index:The routine blood/urine/feces test, and the liver and kidney function tests of treated group were within the normal range. two groups had no unhealthy response.Conclusion:From preliminary clinical research view, YiQiJianPiHuaTan Decoction treatment polycystic ovary syndrome spleen virtual phlegm resistance card, treatment group total has efficiency better than controlled group, may obvious improve patients of clinical symptoms; in West medical indicators aspects, can improve menstrual cycle and the pregnancy situation, reduced weight index, improve more hair F-G scoring, and acne scoring, improve sexual hormone level, reduces ovarian volume, improve Foundation temperature, and no liver kidney function damage, treatment this disease security, and effective, has widely of application prospects. But because of the conditions, the relatively few number of cases studied, outcome measures is relatively simple, requires further in-depth study. |